Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 2/2003

01-04-2003 | Meeting abstract

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock

Authors: S Sobieszczyk, GH Breborowicz, B Kubiaczyk, T Opala

Published in: Critical Care | Special Issue 2/2003

Login to get access

Excerpt

Recombinant factor VII (rFVIIa) (NovoSeven®; Novo Nordisk, Denmark) is mainly indicated for treatment of the patients with haemophilia and inhibitors in the control of perioperative and spontaneous bleeding. However, no information is available on the use of rFVIIa in the treatment of severe and recurrent bleeding and its complications in the obstetrical patients. Treatment difficulties of hemorrhagic shock arise from coagulopathy coexistence. Therefore, the use of rFVIIa in patients suffering from uncontrolled haemorrhage appears to be rational. …
Metadata
Title
Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock
Authors
S Sobieszczyk
GH Breborowicz
B Kubiaczyk
T Opala
Publication date
01-04-2003
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 2/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1994

Other articles of this Special Issue 2/2003

Critical Care 2/2003 Go to the issue

Meeting abstract

Haemodynamic monitoring during high-frequency oscillatory ventilation in adults

Meeting abstract

Bioelectrical impedance analysis as a predictor for survival in patients with systemic inflammatory response syndrome

Meeting abstract

Effects of a low tidal volume ventilation strategy on the pressure/volume curve in ALI/ARDS patients

Meeting abstract

Comparison between continuous versus bolus furosemide administration in oliguric postoperative paediatric cardiac patients

Meeting abstract

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)

Meeting abstract

In vitro activity of imipenem ± aminoglycosides against Pseudomonas aeruginosa and Acinetobacter calcoaceticus / baumanii isolated from patients in ICUs in German hospitals (1999–2002)